Riskpilot← Back to searchSign inGet full accessBiolinum AB
ABActiveOrg 5569015448Rosenvägen 11Engineering activities and related technical consultancy · NACE 7112Est. 20120 employees
Revenue 2025
SEK 0
EBITDA margin
—
+2352% vs 2024
Equity ratio
88.1%
Financial strength
Net profit 2025
SEK 60K
+2089% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK 68K | +2352% |
| Net profit | SEK 60K | +2089% |
| Total assets | SEK 117K | -14% |
| Equity | SEK 103K | +135% |
| Employees | 0 | — |
Legal name
Biolinum AB
Org number
5569015448
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21 augusti 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom bygg-, industri och elsektorn avseende organisationsutveckling, management, miljö-, kvalitets- och inköpsfrågor samt utbildning, rådgivning och därmed förenlig verksamhet. Bolaget skall även tillhandhålla IT-tjänster inom bygg- och industrisektorn såsom CAD-uppritning, teknisk dokumentation och ekonomiadministration. Bolaget ska även bedriva förvaltning av aktier och värdepapper samt därmed förenlig verksamhet.
Address
Rosenvägen 11
Email
birgitta156630@msn.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | −1 | −1 | −3 | 68 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −1 | −1 | −1 | −3 | 68 |
| Net financials | — | — | — | — | 6 |
| Profit before tax | −1 | −1 | −1 | −3 | 74 |
| Tax | −0 | −0 | −0 | −0 | −14 |
| Net profit | −1 | −1 | −1 | −3 | 60 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 140 | 139 | 139 | 136 | 117 |
| Equity | 48 | 46 | 46 | 44 | 103 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 93 | 93 | 93 | 93 | 14 |
| Total debt | 93 | 93 | 93 | 93 | 14 |
EBITDA margin
6757200.0%
This company
15.8%
Market median
+42766989% vs market
20212025
Equity ratio
88.1%
This company
38.2%
Market median
+131% vs market
20212025
Return on equity
57.7%
This company
18.4%
Market median
+214% vs market
20212025
Net profit margin
5967000.0%
This company
8.1%
Market median
+73666567% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biolinum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Johan Anton Mårstedt | Deputy Board Member | 0 companies |
| Jon Kristian Olsson | Deputy Board Member | 0 companies |
| Birgitta Mårstedt | Board of Directors | 0 companies |